TCIM
ASPX

TIAA CREF Investment Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

TIAA CREF Investment Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-52,449
Closed -$5.26M – 3260
2015
Q1 		$5.26M Buy
52,449
+2,608
+5% +$174K ﹤0.01% 1601
2014
Q4 		$2.62M Buy
49,841
+760
+2% +$22.3K ﹤0.01% 2071
2014
Q3 		$1.26M Sell
49,081
-1,362
-3% -$29K ﹤0.01% 2508
2014
Q2 		$1.12M Buy
50,443
+20,409
+68% +$446K ﹤0.01% 2656
2014
Q1 		$924K Buy
+30,034
New +$807K ﹤0.01% 2683

TIAA CREF Investment Management's ASPX Position: Q2 2015 in Review

TIAA CREF Investment Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 52,449 shares — an estimated $5.26M sold.

TIAA CREF Investment Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $5.26M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • TIAA CREF Investment Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • TIAA CREF Investment Management sold 52,449 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $5.26M.
  • TIAA CREF Investment Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • TIAA CREF Investment Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $5.26M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on TIAA CREF Investment Management's 13F filing for Q2 2015, filed 10 Aug 2015.